Lung cancer continues to be a major global health problem; the disease is diagnosed in
more than 1.6 million new patients each year. However, significant progress is underway in …

Lung cancer is the leading cause of cancer mortality, and radiotherapy plays a key role in
both curative and palliative treatments for this disease. Recent advances include stereotactic …

Background Lung stereotactic body radiotherapy (SBRT) is considered a standard curative
treatment for medically inoperable early stage non–small-cell lung cancer (NSCLC) …

Purpose Stereotactic body radiation therapy (SBRT) has become the standard of care for
inoperable early-stage non-small cell lung cancer and is often used for recurrent lung …

Stereotactic ablative body radiotherapy (SABR) describes a radiotherapy (RT) technique
where high doses of radiation are precisely delivered to an extracranial target within the …

The 21st century has seen several paradigm shifts in the treatment of non-small cell lung
cancer (NSCLC) in early-stage inoperable disease, definitive locally advanced disease, and …

Objectives Stereotactic body radiation therapy (SBRT) is now the standard of care in
medically inoperable stage I NSCLC, yielding high rates of local control. It is unknown …

Background and purpose Recent studies have postulated that patients undergoing lung
stereotactic body radiotherapy (SBRT) for ultracentral tumors have higher toxicity and …

Stereotactic body radiation therapy (SBRT) offers excellent local control of early-stage non-
small cell lung cancer (NSCLC), but there currently is a need for tolerable systemic therapy …

Stereotactic body radiation therapy (SBRT) is an effective and well tolerated treatment for
early stage non-small cell lung cancer (NSCLC). The high doses used in thoracic SBRT can …